Last reviewed · How we verify
NCT00745771
Multiple Dose, Double-Blind, Double-Dummy, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness From Exercise
Phase 2 trial testing Diractin in Muscle Soreness in 168 participants. Completed in 1 November 2008.
1 February 2008
Quick facts
| Lead sponsor | IDEA AG |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Primary purpose | treatment |
| Enrollment | 168 |
| Start date | 1 October 2007 |
| Primary completion | 1 February 2008 |
| Estimated completion | 1 November 2008 |
| Sites | 1 location across Germany |
Drugs / interventions tested
Conditions studied
- Muscle Soreness — all drugs for Muscle Soreness →
Sponsor
IDEA AG — full company profile →
Who can join
Adults 18 to 55, any sex, with Muscle Soreness. Healthy volunteers can join.
Sponsor's own description
Multiple-dose, double-blind, double-dummy, parallel, randomized, placebo and active controlled study of pharmacokinetics of Diractin® as well as safety and efficacy for muscle soreness from exercise.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00745771
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Soreness
Currently open trials in the same condition.
- NCT07005934 — Effects of Percussion Therapy on the Biomechanics of Pickleball Movement · NA · active not recruiting
- NCT06804564 — Cold Vs Warm Water Immersion for DOMS Recovery · NA · recruiting
- NCT03660969 — Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00745771 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IDEA AG
- Last refreshed: 19 March 2009
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00745771.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing